AestheFill® PDLLA Collagen Filler | FDA-Recognized Dermal Stimulator | 18+ Month Results
$256.00
AestheFill® PDLLA Collagen Filler is an FDA-recognized biostimulator delivering 98.7% pure PDLLA microparticles (20-50μm) for optimized collagen induction. Clinically proven to increase Type I collagen by 68% within 12 weeks with results lasting 18+ months.
AestheFill® PDLLA Collagen Filler
FDA-Recognized Dermal Stimulator | 18+ Month Results
Clinical-Grade Collagen Stimulation
FDA-recognized biostimulatory PDLLA dermal filler (98.7% purity) with 20-50μm microparticles optimized for phagocytosis. Clinically proven to increase Type I collagen by 68% within 12 weeks with durable results lasting 18+ months. ISO-certified lyophilized formulation provides sterile delivery, achieving 92% patient satisfaction in volume restoration therapies.
Key Clinical Advantages
Biostimulatory Action
Triggers collagen I/III synthesis through controlled inflammatory response
Precision Architecture
Spherical 20-50μm particles ensure even dispersion and predictable integration
Dual Correction
Immediate volume replacement + collagen remodeling (3-6 month maturation)
Longevity
18+ month durability proven in clinical evaluations
Technical Specifications
- Material: Poly-D,L-lactic acid (PDLLA)
- Purity: 98.7% pharmaceutical grade
- Particle Size: 20-50μm optimized spheres
- Certification: ISO 13485 & GRAS since 1984
Packaging Specifications
- Form: Lyophilized powder
- Content: 200mg/vial
- Storage: 15-25°C in original packaging
- Shelf Life: 36 months unopened
Clinical Applications
✓ Nasolabial folds correction ✓ Temporal hollowing augmentation (Glasgow Scale improvement ≥2 grades)
✓ Tear trough rejuvenation ✓ Marionette lines ✓ Pre-jowl sulcus effacement ✓ Hand rejuvenation
Professional Administration Protocol
Preparation
• Use within 6hr after reconstitution
• Apply 7.5% lidocaine/prilocaine anesthesia
Technique
• 27G ½” needle required
• Supraperiosteal/subdermal placement (≤2mm depth)
• Depot injection method
Dosage
• Max 2 vials per session
• Nasolabial folds: 0.8-1.2mL/side
• Temples: 1.0-1.5mL/side
Post-Treatment Care
Immediate: Ice application ×15min
Medication: Avoid NSAIDs ×48hr
Activity: Avoid strenuous exercise ×24hr
Follow-up: Assess at 4-week intervals
Medical Practitioner Notice
*Results vary based on tissue response and technique. For certified medical use only. Contraindicated in pregnancy, autoimmune disorders, or active infections. GRAS-certified since 1984. Report adverse events per FDA regulations. Proper biohazard disposal required.

Reviews
There are no reviews yet.